title: Methyl isobutyl ketone exposure-related increases in specific measures of α2u-globulin (α2u) nephropathy in male rats along with in vitro evidence of reversible protein binding.
abstract: Chronic exposure to methyl isobutyl ketone (MIBK) resulted in an increase in the incidence of renal tubule adenomas and occurrence of renal tubule carcinomas in male, but not female Fischer 344 rats. Since a number of chemicals have been shown to cause male rat renal tumors through the α2u nephropathy-mediated mode of action, the objective of this study is to evaluate the ability of MIBK to induce measures of α2u nephropathy including renal cell proliferation in male and female F344 rats following exposure to the same inhalation concentrations used in the National Toxicology Program (NTP) cancer bioassay (0, 450, 900, or 1800ppm). Rats were exposed 6h/day for 1 or 4 weeks and kidneys excised approximately 18h post exposure to evaluate hyaline droplet accumulation (HDA), α2u staining of hyaline droplets, renal cell proliferation, and to quantitate renal α2u concentration. There was an exposure-related increase in all measures of α2u nephropathy in male, but not female rat kidneys. The hyaline droplets present in male rat kidney stained positively for α2u. The changes in HDA and α2u concentration were comparable to d-limonene, an acknowledged inducer of α2u nephropathy. In a separate in vitro study using a two-compartment vial equilibration model to assess the interaction between MIBK and α2u, the dissociation constant (Kd) was estimated to be 1.27×10(-5)M. This Kd is within the range of other chemicals known to bind to α2u and cause nephropathy. Together, the exposure-related increase in measures of α2u nephropathy, sustained increase in renal cell proliferation along with an indication of reversible binding of MIBK to α2u, support the inclusion of MIBK in the category of chemicals exerting renal effects through a protein droplet α2u nephropathy-mediated mode of action (MoA).
authors: ToxStrategies, Inc., Cary, NC, United States. Electronic address: sborghoff@toxstrategies.com.
authors: S J
authors: SJ
authors: Borghoff
authors: Summit Toxicology, LLC, Richland, WA, United States.
authors: T S
authors: TS
authors: Poet
authors: Eastman Chemical Company, Kingsport, TN, United States.
authors: S
authors: S
authors: Green
authors: Integrated Laboratory Systems, Inc., Research Triangle Park, NC, United States.
authors: J
authors: J
authors: Davis
authors: Dow Chemical Company, Midland, MI, United States.
authors: B
authors: B
authors: Hughes
authors: Sasol Solvents, Moers, Germany.
authors: T
authors: T
authors: Mensing
authors: Shell International, Houston, TX, United States.
authors: S S
authors: SS
authors: Sarang
authors: American Chemistry Council, Washington D.C., United States.
authors: A M
authors: AM
authors: Lynch
authors: Private Consultant, Tairua, New Zealand.
authors: G C
authors: GC
authors: Hard
mesh_terms: D000510:Alpha-Globulins / Q000378:metabolism*; D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D019570:Inhalation Exposure; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008742:Methyl n-Butyl Ketone / Q000378:metabolism / Q000633:toxicity*; D009929:Organ Size; D011485:Protein Binding; D011916:Rats, Inbred F344; D018570:Risk Assessment; D012737:Sex Factors; D015398:Signal Transduction / Q000187:drug effects; D012997:Solvents / Q000378:metabolism / Q000633:toxicity*; D013997:Time Factors
chemical_list: D000510:Alpha-Globulins; D012997:Solvents; C013803:alpha 2u globulin; D008742:Methyl n-Butyl Ketone; C005458:methyl isobutyl ketone
keywords: Hyaline droplet accumulation; Methyl isobutyl ketone; α2u-Globulin; α2u-Nephropathy